Advertisement

Drug Abuse in Athletes

  • Nancy A. Nuzzo
  • Donald P. Waller

Abstract

The trainers would bring your medication to your hotel room the night before the game. Empirin compound for men in pain, amphetamine for men expecting pain, specialty drugs for players with chronic injuries, experimental drugs for those who had little body left to sacrifice, including butazolidin for joint pain (a drug also used to treat horses) and of course, sleeping pills.1

Keywords

Anabolic Steroid Young Athlete Recreational Drug Professional Sport National Collegiate Athletic Association 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gent P: Between the white lines. Dallas Times Herald,4 Sept 1983, Magazine section, p 13.Google Scholar
  2. 2.
    Willians MH: Drugs and Athletic Performance. Springfield, IL, Charles C Thomas, 1974.Google Scholar
  3. 3.
    Prokop L: The problem of doping. Final report on the international doping conference. FIMS congress, Tokyo, October, 1964. J Sport Med 5: 88–90, 1965.Google Scholar
  4. 4.
    Toohey JV: Nonmedical drug use among intercollegiate athletes at five American Universities. Bull Narc 30: 61–64, 1978.PubMedGoogle Scholar
  5. 5.
    Vinger PF, Hoerner EF: Sports Injuries. Littleton, MA, PSG Publishing Company, Inc., 1986.Google Scholar
  6. 6.
    Goldman B: Death in the Locker Room. South Bend, IN, ICARUS Press, 1984.Google Scholar
  7. 7.
    Gledhill N: Blood doping and related issues: A brief review. Med Sci Sports Exerc 14: 183–189, 1982.PubMedGoogle Scholar
  8. 8.
    Gledhill N, Buick FJ, Froese AB, et al: An optimal method of storing blood for blood boosting. Med Sci Sports 10: 40, 1978.Google Scholar
  9. 9.
    Berglund B, Hemmingsson P, Birgegard G: Detection of autologous blood transfusiôns in cross-country skiers. Int J Sports Med 8: 66–70, 1987.PubMedCrossRefGoogle Scholar
  10. 10.
    Sutton JR: Drugs in sport. Physician Sportsmed 11: 63–101, 1983.Google Scholar
  11. 11.
    Gledhill N: Bicarbonate ingestion and anaerobic performance. Sports Med 1:177–180, 1984.Google Scholar
  12. 12.
    Wilkes D, Gledhill N, Smyth R: Effect of acute induced metabolic alkalosis on 800m racing time. Med Sci Sports Med Exerc 15: 277–280. 1983.CrossRefGoogle Scholar
  13. 13.
    Mudge GH: Agents affecting volume and composition of body fluids, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, p 865.Google Scholar
  14. 14.
    Vanhelder WP, Radomski MW, Goode RC: Growth hormone responses during intermittent weight lifting exercise in men. Eur J Appl Physiol 53: 31–34, 1984.CrossRefGoogle Scholar
  15. 15.
    Vanhelder WP, Casey K, Goode RC, et al: Growth hormone regulation in two types of aerobic exercise of equal oxygen uptake. Eur J Appl Physiol 55: 236–239, 1986.CrossRefGoogle Scholar
  16. 16.
    Murad R, Haynes RC Jr: Adenohypophyseal hormones and related substances, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 1366–1372.Google Scholar
  17. 17.
    Macintyre JG: Growth hormone and athletes. Sports Med 4: 129–142, 1987.PubMedCrossRefGoogle Scholar
  18. 18.
    Daughaday WH: The anterior pituitary, in Williams RH (ed): Textbook of Endocrinology, ed 7. Philadelphia, WB Saunders Co., 1985, pp 568–613.Google Scholar
  19. 19.
    Lamb DR: Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 12 (1): 31–38, 1984.PubMedCrossRefGoogle Scholar
  20. 20.
    Bergman R, Leach RE: The use and abuse of anabolic steroids in olympic-caliber athletes. Clin Orthop Rel Res, No. 198, September 1985.Google Scholar
  21. 21.
    Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 1 (6): 469–484, 1984.CrossRefGoogle Scholar
  22. 22.
    Zurer PS: Drugs in sports. Chem Eng News 30: 69–78, 1984.CrossRefGoogle Scholar
  23. 23.
    Alen M, Rahkila P: Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor. Int J Sports Med 5: 341–342, 1984.PubMedCrossRefGoogle Scholar
  24. 24.
    Alen M. Rahkila P, Marniemi J: Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 6: 139–144, 1985.PubMedCrossRefGoogle Scholar
  25. 25.
    Dyment PG: Drugs and the adolescent athlete. Ped Ann 13 (8): 602–604, 1984.Google Scholar
  26. 26.
    Gardiner PF: Anti-inflammatory medications. Physician Sportsmed 11 (9): 71–74, 1983.Google Scholar
  27. 27.
    Haynes RC, Murad F: Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs: inhibitors of adrenocortical steroid biosynthesis, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 1459–1489.Google Scholar
  28. 28.
    Flower RJ, Moncada S, Vane JR: Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 674–715.Google Scholar
  29. 29.
    Wagner JC: Substance-abuse policies and guidelines in amateur and professional athletics. Am J Hosp Pharm 44: 305–310, 1987.PubMedGoogle Scholar
  30. 30.
    Smith GM, Beecher HK: Amphetamine sulfate and athletic performance. I. Objective effects. JAMA 170:542–557, 1959CrossRefGoogle Scholar
  31. 31.
    Chandler JV, Blair SN: The effects of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc 12: 65–69, 1980.PubMedGoogle Scholar
  32. 32.
    Bhagat B, Wheeler N: Effect of amphetamine on the swimming endurance of rats. Neuropharmacology 12: 711–713, 1973.PubMedCrossRefGoogle Scholar
  33. 33.
    Gerald MC: Effects of (+)-amphetamine on the treadmill endurance performance of rats. Neuropharmacology 17: 703–704, 1978.PubMedCrossRefGoogle Scholar
  34. 34.
    Morgan JP: The clinical pharmacology of amphetamine, in Smith DE (ed): Amphetamine Use, Misuse and Abuse. Boston, GH Hall & Co, 1979, pp 3–10.Google Scholar
  35. 35.
    Weiner N: Norpinephrine, epinephrine, and the sympathomimetic amines, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 145–180.Google Scholar
  36. 36.
    Wood DS: Human skeletal muscle: Analysis of Ca+ regulation in skinned fibers using caffeine. Exp Neurol 58: 218–230, 1978.PubMedCrossRefGoogle Scholar
  37. 37.
    Lopes JM, Aubier M, Jardim J, Aranda, JV, Macklem, PT: Effect of caffeine on skeletal muscle function before and after fatigue. J Appl Physiol Respirat Environ Exercise Physiol 54 (5): 1303–1305, 1983.Google Scholar
  38. 38.
    Scherer JC, in Lippincott’s Nurses’ Drug Manual. Philadelphia, JB Lippincott Co., 1985, p 223.Google Scholar
  39. 39.
    Rall TW: Central nervous system stimulants, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 589–603.Google Scholar
  40. 40.
    Fitch KD: The use of anti-asthmatic drugs. Do they affect sports performance? Sports Med 3: 136–150, 1986.PubMedCrossRefGoogle Scholar
  41. 41.
    Dollars & Sense, Dec 1986, pp 6–8.Google Scholar
  42. 42.
    Clement DB: Drug use survey: results and conclusions. Physician Sportsmed 11: 64–67, 1983.Google Scholar
  43. 43.
    Puffer JC: The use of drugs in swimming Clin Sports Med 5 (1): 77–89, 1986.PubMedGoogle Scholar
  44. 44.
    Weimer WW, Russell JA, Kaplan HL: Ethanol toxicology, in Alcohols Toxicology. Park Ridge, IL, Noyes Data Corporation, 1983, pp 27–45.Google Scholar
  45. 45.
    Ritchie IM: The aliphatic alcohols, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics,ed 7. New York, Macmillan Publishing Co., 1985, pp 372386.Google Scholar
  46. 46.
    Abel EL: Pharmacology of cannabinoids, in Marihuana, Tobacco, Alcohol and Reproduction. Boca Raton, FL, CRC Press, Inc, 1983, pp 1–7.Google Scholar
  47. 47.
    Ovack K: Cocaine unpredictability makes using drug a deadly gamble. St Petersburg Times (St Petersburg, FL) 13 July 1986, p Fl.Google Scholar
  48. 48.
    Kuchenski R: Biochemical actions of amphetamine and other stimulants, in Creese I (ed): Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. New York, Raven Press, 1983, pp 31–61.Google Scholar
  49. 49.
    Post RM, Contel NR: Human and animal studies of cocaine: Implications for development of behavioral pathology, in Creese I (ed): Stimulants: Neurochemical, Behavioral, and Clinical Perspectives, New York. Raven Press, 1983, pp 169–203.Google Scholar
  50. 50.
    Jaffe JH: Drug addiction and drug abuse, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics,ed 7. New York, Macmillan Publishing Co., 1985, pp 532580.Google Scholar
  51. 51.
    Beckett AH: Use and abuse of drugs in sport. J Biosoc Sci (suppl 7 ): 163–170, 1981.Google Scholar
  52. 52.
    Catlin DH, Kammerer RC, Hatton CK, et al: Analytical chemistry at the games of the XXIIIrd Olympiad in Los Angeles, 1984. Clin Chem 33: 319–327, 1987.PubMedGoogle Scholar
  53. 53.
    Sutton JR: Drugs in sport. Physician Sportsmed 11: 63–101, 1983.Google Scholar
  54. 54.
    Hersh P: Drug tests take weighty toll. Chicago Tribune, 27 July 1987, p 8.Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Nancy A. Nuzzo
    • 1
  • Donald P. Waller
    • 1
  1. 1.College of PharmacyUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations